Supernus Pharmaceuticals advertising spend, FY2025

Supernus Pharmaceuticals (SUPN) reported $96.1M of advertising expense for the fiscal year ended Dec 31, 2025. That is 13.4% of revenue of $719M. Up 8.6% from FY2024.

Ad spend, FY2025
$96.1M
year ended Dec 31, 2025
Change vs prior year
+8.6%
vs FY2024
Share of revenue
13.4%
of $719M revenue
Rank by ad spend
#347
of 458 companies

Key facts

  • Ad spend is 1.8x its FY2020 level ($54.5M), faster than revenue (1.4x).
  • The highest year on file is FY2022 at $132M; FY2025 is 27% below it.
  • Largest increase +57.8% in FY2021; largest cut -24.3% in FY2023.
  • Ad spend is 13.4% of revenue, up from 10.5% in FY2020.
  • Supernus Pharmaceuticals spends more on advertising than 24% of the 458 US-listed companies tracked. Its ad-to-revenue ratio is 2.9x the median of 4.6%.

Ad spend by fiscal year

$0 $50M $100M $150M FY2014 (ended 2014-12-31): $14.8M 2014 FY2018 (ended 2018-12-31): $43.3M FY2019 (ended 2019-12-31): $40.8M 2019 FY2020 (ended 2020-12-31): $54.5M FY2021 (ended 2021-12-31): $86M 2021 FY2022 (ended 2022-12-31): $132M FY2023 (ended 2023-12-31): $99.7M 2023 FY2024 (ended 2024-12-31): $88.5M FY2025 (ended 2025-12-31): $96.1M 2025 $96.1M

Ad spend as % of revenue

0% 5% 10% 15% 20% FY2014 (ended 2014-12-31): 16.0% 2014 FY2018 (ended 2018-12-31): 10.6% FY2019 (ended 2019-12-31): 10.4% 2019 FY2020 (ended 2020-12-31): 10.5% FY2021 (ended 2021-12-31): 14.8% 2021 FY2022 (ended 2022-12-31): 19.7% FY2023 (ended 2023-12-31): 16.4% 2023 FY2024 (ended 2024-12-31): 13.4% FY2025 (ended 2025-12-31): 13.4% 2025 13.4%

History

Download CSV
Fiscal year Period end Ad spend YoY Revenue Ad / revenue Tag Filing
FY2025 Dec 31, 2025 $96.1M +8.6% $719M 13.4% AdvertisingExpense 10-K Mar 2, 2026
FY2024 Dec 31, 2024 $88.5M -11.2% $662M 13.4% AdvertisingExpense 10-K Mar 2, 2026
FY2023 Dec 31, 2023 $99.7M -24.3% $608M 16.4% AdvertisingExpense 10-K Mar 2, 2026
FY2022 Dec 31, 2022 $132M +53.1% $667M 19.7% AdvertisingExpense 10-K Feb 25, 2025
FY2021 Dec 31, 2021 $86M +57.8% $580M 14.8% AdvertisingExpense 10-K Mar 9, 2023
FY2020 Dec 31, 2020 $54.5M +33.6% $520M 10.5% AdvertisingExpense 10-K Mar 9, 2023
FY2019 Dec 31, 2019 $40.8M -5.8% $393M 10.4% AdvertisingExpense 10-K Apr 13, 2022
FY2018 Dec 31, 2018 $43.3M n/a $409M 10.6% AdvertisingExpense 10-K Mar 8, 2021
FY2014 Dec 31, 2014 $14.8M n/a $92.7M 16.0% AdvertisingExpense 10-K Mar 12, 2015

What the figure is

Advertising costs as disclosed in the annual report (XBRL tag AdvertisingExpense).

Compared with similar spenders

The 6 companies closest to Supernus Pharmaceuticals in latest-year ad spend.

Rank Company Ad spend Ad / revenue YoY Fiscal year
343 ADT $98M 1.9% -6.7% FY2025
344 Advance Auto Parts $98M 1.1% n/a FY2026
345 Laureate Education $97.6M 5.7% +10.3% FY2025
346 LightInTheBox $96.8M 43.2% -7.2% FY2025
347 Supernus Pharmaceuticals $96.1M 13.4% +8.6% FY2025
348 Cloudflare $95.2M 4.4% +21.1% FY2025
349 Group 1 Automotive $94.5M 0.4% -1.8% FY2025

Full ranking of 458 companies · Biggest increases #195

Questions

How much does Supernus Pharmaceuticals spend on advertising?

Supernus Pharmaceuticals spent $96.1M on advertising in fiscal 2025, the year ended Dec 31, 2025, according to its 10-K filed Mar 2, 2026.

What percentage of revenue does Supernus Pharmaceuticals spend on advertising?

13.4% of revenue in fiscal 2025 ($96.1M of $719M). The median across the 458 companies tracked is 4.6%.

Is Supernus Pharmaceuticals spending more on advertising?

Yes. Ad spend rose 8.6% in fiscal 2025 from fiscal 2024.

How does Supernus Pharmaceuticals rank by advertising spend?

#347 of 458 US-listed companies with $50M or more in ad spend, ranked on each company's latest fiscal year.

What does Supernus Pharmaceuticals's advertising figure include?

Advertising costs as disclosed in the annual report (XBRL tag AdvertisingExpense).

Source

Filing
10-K for FY2025, filed Mar 2, 2026
Accession number
0001356576-26-000011
Company
SUPERNUS PHARMACEUTICALS, INC., CIK 1356576, SIC 2834 (Pharmaceutical Preparations)
Data
SEC EDGAR XBRL company facts, retrieved Nov 4, 2026. Methodology.
Cite
Supernus Pharmaceuticals advertising spend, FY2014-FY2025. Aleksei Trudov, io.trudov.com, from SEC EDGAR XBRL company facts (latest: 10-K filed Mar 2, 2026), retrieved Nov 4, 2026. https://io.trudov.com/company/supernus-pharmaceuticals/advertising-spend/
Download
CSV, all years · CSV, all 458 companies